Trials / Completed
CompletedNCT00367614
Study Evaluating Pantoprazole in Adolescents With GERD
A Multicenter, Randomized, Open-Label, Single And Multiple Dose Study Of The Pharmacokinetics And Safety of Two Dose Levels of Pantoprazole Sodium Tablets In Adolescents Aged 12 Through 16 Years With A Clinical Daignosis Of GERD.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 12 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is characterize the PK profile of single and multiple doses of pantoprazole in adolescents aged 12 to 16 years with Gastroesophageal Reflux Disease (GERD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pantoprazole |
Timeline
- Start date
- 2007-01-01
- Completion
- 2007-08-01
- First posted
- 2006-08-23
- Last updated
- 2007-12-10
Source: ClinicalTrials.gov record NCT00367614. Inclusion in this directory is not an endorsement.